# Firefly Aerospace Inc.: financial statements, quarterly

FLY · Nasdaq · CIK 1860160 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fly.md) · [Financials](/companies/fly/financials.md) · [Filings](/companies/fly/filings.md) · [Insiders](/companies/fly/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fly/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [21.1](/filings/0001193125-25-211265.md) | [22.4](/filings/0001193125-25-277941.md) | [9.0 d](/filings/0001193125-26-116309.md) | [55.9](/filings/0001860160-26-000009.md) | [15.5](/filings/0001860160-26-000023.md) | [30.8](/filings/0001193125-25-277941.md) | [57.7 d](/filings/0001193125-26-116309.md) | [80.9](/filings/0001860160-26-000009.md) | [118](/filings/0001860160-26-000023.md) |
| Cost of revenue | $m | not reported | [18.1](/filings/0001193125-25-211265.md) | [14.6](/filings/0001193125-25-277941.md) | [29.2 d](/filings/0001193125-26-116309.md) | [53.6](/filings/0001860160-26-000009.md) | [11.6](/filings/0001860160-26-000023.md) | [22.3](/filings/0001193125-25-277941.md) | [41.7 d](/filings/0001193125-26-116309.md) | [63.4](/filings/0001860160-26-000009.md) | [93.8](/filings/0001860160-26-000023.md) |
| Gross profit | $m | not reported | [3.0](/filings/0001193125-25-211265.md) | [7.8](/filings/0001193125-25-277941.md) | [(20.2) d](/filings/0001193125-26-116309.md) | [2.2](/filings/0001860160-26-000009.md) | [4.0](/filings/0001860160-26-000023.md) | [8.5](/filings/0001193125-25-277941.md) | [16.0 d](/filings/0001193125-26-116309.md) | [17.5](/filings/0001860160-26-000009.md) | [23.9](/filings/0001860160-26-000023.md) |
| Research and development | $m | not reported | [39.5](/filings/0001193125-25-211265.md) | [29.9](/filings/0001193125-25-277941.md) | [42.5 d](/filings/0001193125-26-116309.md) | [48.0](/filings/0001860160-26-000009.md) | [45.8](/filings/0001860160-26-000023.md) | [48.8](/filings/0001193125-25-277941.md) | [57.6 d](/filings/0001193125-26-116309.md) | [67.5](/filings/0001860160-26-000009.md) | [71.5](/filings/0001860160-26-000023.md) |
| Selling, general and administrative | $m | not reported | [12.3](/filings/0001193125-25-211265.md) | [10.3](/filings/0001193125-25-277941.md) | [14.7 d](/filings/0001193125-26-116309.md) | [12.8](/filings/0001860160-26-000009.md) | [12.6](/filings/0001860160-26-000023.md) | [21.9](/filings/0001193125-25-277941.md) | [44.0 d](/filings/0001193125-26-116309.md) | [45.6](/filings/0001860160-26-000009.md) | [47.5](/filings/0001860160-26-000023.md) |
| Operating income | $m | not reported | [(48.9)](/filings/0001193125-25-211265.md) | [(34.2)](/filings/0001193125-25-277941.md) | [(77.2) d](/filings/0001193125-26-116309.md) | [(58.5)](/filings/0001860160-26-000009.md) | [(54.4)](/filings/0001860160-26-000023.md) | [(62.2)](/filings/0001193125-25-277941.md) | [(85.6) d](/filings/0001193125-26-116309.md) | [(95.7)](/filings/0001860160-26-000009.md) | [(95.2)](/filings/0001860160-26-000023.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [6.2](/filings/0001860160-26-000009.md) | [7.0](/filings/0001860160-26-000023.md) | not reported | not reported | [3.6](/filings/0001860160-26-000009.md) | [1.8](/filings/0001860160-26-000023.md) |
| Income tax | $m | not reported | [0.0](/filings/0001193125-25-211265.md) | [0.0](/filings/0001193125-25-277941.md) | [0.0 d](/filings/0001193125-26-116309.md) | [0.0](/filings/0001860160-26-000009.md) | [0.0](/filings/0001860160-26-000023.md) | [0.0](/filings/0001193125-25-277941.md) | [(37.1) d](/filings/0001193125-26-116309.md) | [0.1](/filings/0001860160-26-000009.md) | [(0.0)](/filings/0001860160-26-000023.md) |
| Net income | $m | [(52.8)](/filings/0001193125-25-277941.md) | [(53.5)](/filings/0001193125-25-277941.md) | [(40.8)](/filings/0001193125-25-277941.md) | [(84.1) d](/filings/0001193125-26-116309.md) | [(60.1)](/filings/0001860160-26-000023.md) | [(63.8)](/filings/0001860160-26-000023.md) | [(133)](/filings/0001193125-25-277941.md) | [(41.1) d](/filings/0001193125-26-116309.md) | [(96.7)](/filings/0001860160-26-000023.md) | [(92.3)](/filings/0001860160-26-000023.md) |
| Diluted EPS | $ per share | not reported | [(4.60)](/filings/0001193125-25-211265.md) | [(3.57)](/filings/0001193125-25-277941.md) | not reported | [(5.38)](/filings/0001860160-26-000009.md) | [(5.78)](/filings/0001860160-26-000023.md) | [(1.50)](/filings/0001193125-25-277941.md) | not reported | [(0.61)](/filings/0001860160-26-000009.md) | [(0.57)](/filings/0001860160-26-000023.md) |
| Basic EPS | $ per share | not reported | [(4.60)](/filings/0001193125-25-211265.md) | [(3.57)](/filings/0001193125-25-277941.md) | not reported | [(5.38)](/filings/0001860160-26-000009.md) | [(5.78)](/filings/0001860160-26-000023.md) | [(1.50)](/filings/0001193125-25-277941.md) | not reported | [(0.61)](/filings/0001860160-26-000009.md) | [(0.57)](/filings/0001860160-26-000023.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [81.9](/filings/0001193125-26-116309.md) | not reported | [21.9](/filings/0001193125-25-211265.md) | [26.4](/filings/0001193125-25-277941.md) | [123](/filings/0001193125-26-116309.md) | [177](/filings/0001860160-26-000009.md) | [205](/filings/0001860160-26-000023.md) | [995](/filings/0001193125-25-277941.md) | [793](/filings/0001860160-26-000023.md) | [326](/filings/0001860160-26-000009.md) | [460](/filings/0001860160-26-000023.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [181](/filings/0001193125-26-116309.md) | not reported | [234](/filings/0001193125-25-211265.md) | [1,023](/filings/0001193125-25-277941.md) | [963](/filings/0001860160-26-000023.md) | [674](/filings/0001860160-26-000009.md) | [799](/filings/0001860160-26-000023.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [407](/filings/0001193125-26-116309.md) | not reported | [467](/filings/0001193125-25-211265.md) | [1,256](/filings/0001193125-25-277941.md) | [1,825](/filings/0001860160-26-000023.md) | [1,492](/filings/0001860160-26-000009.md) | [1,639](/filings/0001860160-26-000023.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [179](/filings/0001193125-26-116309.md) | not reported | [147](/filings/0001193125-25-211265.md) | [165](/filings/0001193125-25-277941.md) | [214](/filings/0001860160-26-000023.md) | [266](/filings/0001860160-26-000009.md) | [293](/filings/0001860160-26-000023.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [415](/filings/0001193125-26-116309.md) | not reported | [411](/filings/0001193125-25-211265.md) | [307](/filings/0001193125-25-277941.md) | [635](/filings/0001860160-26-000023.md) | [387](/filings/0001860160-26-000009.md) | [416](/filings/0001860160-26-000023.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [113](/filings/0001193125-25-277941.md) | not reported | [136](/filings/0001193125-25-211265.md) | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [6.3](/filings/0001193125-26-116309.md) | not reported | not reported | not reported | [7.1](/filings/0001860160-26-000023.md) | [7.1](/filings/0001860160-26-000009.md) | [7.4](/filings/0001860160-26-000023.md) |
| Shareholders' equity | $m | [(351)](/filings/0001193125-26-116309.md) | [(504)](/filings/0001193125-26-116309.md) | [(562)](/filings/0001193125-25-277941.md) | [620](/filings/0001193125-25-277941.md) | [(665)](/filings/0001193125-25-277941.md) | [(768)](/filings/0001860160-26-000023.md) | [(839)](/filings/0001860160-26-000023.md) | [(918)](/filings/0001860160-26-000023.md) | [949](/filings/0001193125-25-277941.md) | [1,190](/filings/0001860160-26-000023.md) | [1,105](/filings/0001860160-26-000023.md) | [1,223](/filings/0001860160-26-000023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(36.6) d](/filings/0001193125-25-277941.md) | [(40.3) d](/filings/0001193125-26-116309.md) | [(56.5)](/filings/0001860160-26-000009.md) | [(28.1) d](/filings/0001860160-26-000023.md) | [(53.0) d](/filings/0001193125-25-277941.md) | [(67.3) d](/filings/0001193125-26-116309.md) | [(62.5)](/filings/0001860160-26-000009.md) | [(81.6) d](/filings/0001860160-26-000023.md) |
| Capital expenditure | $m | [8.2 d](/filings/0001193125-25-277941.md) | [2.7 d](/filings/0001193125-26-116309.md) | [2.7](/filings/0001860160-26-000009.md) | [9.2 d](/filings/0001860160-26-000023.md) | [8.9 d](/filings/0001193125-25-277941.md) | [12.1 d](/filings/0001193125-26-116309.md) | [16.3](/filings/0001860160-26-000009.md) | [24.7 d](/filings/0001860160-26-000023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.8](/filings/0001193125-25-211265.md) | [12.9](/filings/0001193125-25-277941.md) | [13.4](/filings/0001860160-26-000009.md) | [13.9](/filings/0001860160-26-000023.md) | [93.8](/filings/0001193125-25-277941.md) | [160](/filings/0001860160-26-000009.md) | [162](/filings/0001860160-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 167,404,645 at 2026-08-06, from the cover of the [10-Q filed 2026-08-11](/filings/0001860160-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.